Clinical Trials Directory

Trials / Unknown

UnknownNCT01152593

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
Female
Age
Healthy volunteers

Summary

The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.

Conditions

Interventions

TypeNameDescription
DRUGMupirocinIntranasal cream given to patient after confirmation of colonization

Timeline

Start date
2010-07-01
Primary completion
2014-07-01
Completion
2014-12-01
First posted
2010-06-29
Last updated
2010-06-29

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01152593. Inclusion in this directory is not an endorsement.

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections (NCT01152593) · Clinical Trials Directory